Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

1.

Chemoprevention of breast cancer.

Osborne MP.

Surg Clin North Am. 1999 Oct;79(5):1207-21. Review.

PMID:
10572559
2.

From adjuvant therapy to breast cancer prevention: BCPT and STAR.

Dunn BK, Ford LG.

Breast J. 2001 May-Jun;7(3):144-57. Review.

PMID:
11469927
3.

Chemoprevention of breast cancer in the older patient.

Minton SE.

Hematol Oncol Clin North Am. 2000 Feb;14(1):113-30. Review.

PMID:
10680075
4.

Chemoprevention options for BRCA1 and BRCA2 mutation carriers.

Eeles RA, Powles TJ.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):93S-9S. Review.

PMID:
11060334
5.

Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.

Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI.

Cancer J Sci Am. 2000 Jan-Feb;6(1):13-20.

PMID:
10696733
6.

[Breakthrough in breast cancer chemoprevention].

Kahán Z, Thurzó L.

Orv Hetil. 2003 Mar 30;144(13):597-603. Review. Hungarian.

PMID:
12728784
7.

Chemoprevention for high-risk women: tamoxifen and beyond.

Fabian CJ, Kimler BF.

Breast J. 2001 Sep-Oct;7(5):311-20. Review.

PMID:
11906441
8.

Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.

Kinsinger LS, Harris R, Woolf SH, Sox HC, Lohr KN.

Ann Intern Med. 2002 Jul 2;137(1):59-69. Review.

PMID:
12093250
9.

Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.

Vogel VG.

Clin Cancer Res. 2001 Dec;7(12 Suppl):4413s-4418s; discussion 4411s-4412s. Review.

PMID:
11916233
10.

Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond.

Bao T, Prowell T, Stearns V.

Am J Ther. 2006 Jul-Aug;13(4):337-48. Review.

PMID:
16858170
11.

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH.

J Natl Cancer Inst. 2003 Apr 2;95(7):526-32.

PMID:
12671020
12.

Chemoprevention of breast cancer: implications for postmenopausal women.

Fabian CJ, Kimler BF.

Drugs Aging. 2002;19(1):43-78. Review.

PMID:
11929326
13.

Chemoprevention of breast cancer.

Dalton RR, Kallab AM.

South Med J. 2001 Jan;94(1):7-15. Review.

PMID:
11213947
14.

Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.

Greenwald P.

J Cell Biochem Suppl. 1996;25:29-36. Review.

PMID:
9027595
15.

Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

Veronesi U, Maisonneuve P, Rotmensz N, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Lovison F, Gucciardo G, Muraca MG, Pizzichetta MA, Conforti S, Decensi A, Robertson C, Boyle P; Italian Tamoxifen Study Group..

J Natl Cancer Inst. 2003 Jan 15;95(2):160-5.

PMID:
12529349
16.

Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians.

Peshkin BN, Isaacs C, Finch C, Kent S, Schwartz MD.

J Clin Oncol. 2003 Dec 1;21(23):4322-8.

PMID:
14645421
17.
18.

Reducing the risk of breast cancer with tamoxifen in women at increased risk.

Vogel VG.

J Clin Oncol. 2001 Sep 15;19(18 Suppl):87S-92S. Review.

PMID:
11560980
19.

Breast cancer prevention trials.

Rhodes DJ, Hartmann LC, Perez EA.

Curr Oncol Rep. 2000 Nov;2(6):558-65. Review.

PMID:
11122893
20.

Prevention of hormone-related cancers: breast cancer.

Dunn BK, Wickerham DL, Ford LG.

J Clin Oncol. 2005 Jan 10;23(2):357-67. Review.

PMID:
15637398

Supplemental Content

Support Center